ARCHIVES

NCI advisory Group, Other Cancer Meetings

This article is from The Cancer Letter archive.

Vol. 11 No. 13 | March 29, 1985

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976

Six Years into The Drug Shortage, And The Causes Are Still a Mystery

October 14, 2011

Edward Benz Named President Of Dana-Farber Cancer Institute.

July 28, 2000

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012

Conference Split Difference, NCI Gets $1.075 Billion

October 21, 1983